Literature DB >> 25355882

PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6.

Miranda Thomas1, Lawrence Banks2.   

Abstract

High-risk human papillomavirus (HPV) E6 proteins have a C-terminal PDZ binding motif through which they bind, and target for proteasome-mediated degradation, a number of PDZ-containing cellular targets. Recent studies have suggested that the RING-containing ubiquitin-protein ligase PDZRN3 might also be an HPV E6 target. In this analysis, we show that HPV-16 and HPV-18 E6 can target PDZRN3 in a PDZ- and proteasome-dependent manner and provide a connection between the HPV life cycle and differentiation-related STAT signaling.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25355882      PMCID: PMC4300655          DOI: 10.1128/JVI.01743-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.

Authors:  S Nakagawa; J M Huibregtse
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes.

Authors:  Ji-Ae Ko; Yoshihiro Kimura; Kenji Matsuura; Hisato Yamamoto; Toshikazu Gondo; Makoto Inui
Journal:  J Cell Sci       Date:  2006-11-21       Impact factor: 5.285

4.  The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.

Authors:  Miranda Thomas; Paola Massimi; Christel Navarro; Jean-Paul Borg; Lawrence Banks
Journal:  Oncogene       Date:  2005-09-15       Impact factor: 9.867

5.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance.

Authors:  Nicole Brimer; Scott B Vande Pol
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

7.  Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.

Authors:  D Gardiol; C Kühne; B Glaunsinger; S S Lee; R Javier; L Banks
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

8.  Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons.

Authors:  A Meinke; F Barahmand-Pour; S Wöhrl; D Stoiber; T Decker
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

9.  The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.

Authors:  Marie L Nguyen; Minh M Nguyen; Denis Lee; Anne E Griep; Paul F Lambert
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells.

Authors:  Karin Butz; Tutik Ristriani; Arnd Hengstermann; Claudia Denk; Martin Scheffner; Felix Hoppe-Seyler
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

View more
  9 in total

1.  Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization.

Authors:  Sydney Webb Strickland; Nicole Brimer; Charles Lyons; Scott B Vande Pol
Journal:  Virology       Date:  2018-01-12       Impact factor: 3.616

Review 2.  The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.

Authors:  Ketaki Ganti; Justyna Broniarczyk; Wiem Manoubi; Paola Massimi; Suruchi Mittal; David Pim; Anita Szalmas; Jayashree Thatte; Miranda Thomas; Vjekoslav Tomaić; Lawrence Banks
Journal:  Viruses       Date:  2015-07-02       Impact factor: 5.048

3.  Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.

Authors:  Renaud Vincentelli; Katja Luck; Juline Poirson; Jolanta Polanowska; Julie Abdat; Marilyne Blémont; Jeremy Turchetto; François Iv; Kevin Ricquier; Marie-Laure Straub; Anne Forster; Patricia Cassonnet; Jean-Paul Borg; Yves Jacob; Murielle Masson; Yves Nominé; Jérôme Reboul; Nicolas Wolff; Sebastian Charbonnier; Gilles Travé
Journal:  Nat Methods       Date:  2015-06-08       Impact factor: 28.547

4.  A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models.

Authors:  Carla Amici; Michela Visintin; Francesca Verachi; Francesca Paolini; Zulema Percario; Paola Di Bonito; Angela Mandarino; Elisabetta Affabris; Aldo Venuti; Luisa Accardi
Journal:  Oncotarget       Date:  2016-03-29

5.  Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description.

Authors:  Rodrigo Pinheiro Araldi; Jacqueline Mazzuchelli-de-Souza; Diego Grando Modolo; Edislane Barreiros de Souza; Thatiana Corrêa de Melo; Diva Denelle Spadacci-Morena; Roberta Fiusa Magnelli; Márcio Augusto Caldas Rocha de Carvalho; Paulo Luis de Sá Júnior; Rodrigo Franco de Carvalho; Willy Beçak; Rita de Cassia Stocco
Journal:  Biomed Res Int       Date:  2015-12-09       Impact factor: 3.411

6.  Functional New Transcription Factors (TFs) Associated with Cervical Cancer.

Authors:  Yicheng Jiang; Shi Chen
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

Review 7.  Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?

Authors:  Claire D James; Sally Roberts
Journal:  Pathogens       Date:  2016-01-18

8.  The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis.

Authors:  Floriane Meuris; Laetitia Carthagena; Agnieszka Jaracz-Ros; Françoise Gaudin; Pasquale Cutolo; Claire Deback; Yuezhen Xue; Françoise Thierry; John Doorbar; Françoise Bachelerie
Journal:  PLoS Pathog       Date:  2016-12-05       Impact factor: 6.823

Review 9.  Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.

Authors:  Ethan L Morgan; Andrew Macdonald
Journal:  Viruses       Date:  2020-09-03       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.